Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY

Publication ,  Conference
Armstrong, AJ; Luo, J; Anand, M; Antonarakis, ES; Nanus, DM; Giannakakou, P; Szmulewitz, RZ; Danila, DC; Healy, P; Berry, WR; Wenstrup, R ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
February 20, 2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

February 20, 2020

Volume

38

Issue

6

Location

San Francisco, CA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Luo, J., Anand, M., Antonarakis, E. S., Nanus, D. M., Giannakakou, P., … Halabi, S. (2020). AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY.
Armstrong, Andrew J., Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou, Russell Zelig Szmulewitz, et al. “AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38. AMER SOC CLINICAL ONCOLOGY, 2020.
Armstrong AJ, Luo J, Anand M, Antonarakis ES, Nanus DM, Giannakakou P, et al. AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.
Armstrong, Andrew J., et al. “AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 6, AMER SOC CLINICAL ONCOLOGY, 2020.
Armstrong AJ, Luo J, Anand M, Antonarakis ES, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Berry WR, Wenstrup R, Scher HI, Tagawa ST, George DJ, Halabi S. AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

February 20, 2020

Volume

38

Issue

6

Location

San Francisco, CA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences